Beuvery EC - Search Results

1

Subacute toxicity of Zwittergent administered intramuscularly.

Speijers GJ, Danse LH, Krajnc-Franken MA, van Leeuwen FX, Helleman PW, Beuvery EC, Vos JG, vd Heijden CA. Speijers GJ, et al. Among authors: beuvery ec. Vaccine. 1989 Aug;7(4):364-8. doi: 10.1016/0264-410x(89)90203-x. Vaccine. 1989. PMID: 2815972

2

Local reactions of Zwittergent-containing meningococcal vaccine after intramuscular injection in rats: comparison with the effect of diphtheria-pertussis-tetanus-polio vaccine.

Speijers GJ, Danse LH, Beuvery EC, Derks HJ, Vos JG. Speijers GJ, et al. Among authors: beuvery ec. Vaccine. 1988 Oct;6(5):419-22. doi: 10.1016/0264-410x(88)90142-9. Vaccine. 1988. PMID: 3143190

3

Local reactions of the saponin Quil A and a Quil A containing iscom measles vaccine after intramuscular injection of rats: a comparison with the effect of DPT-polio vaccine.

Speijers GJ, Danse LH, Beuvery EC, Strik JJ, Vos JG. Speijers GJ, et al. Among authors: beuvery ec. Fundam Appl Toxicol. 1988 Apr;10(3):425-30. doi: 10.1016/0272-0590(88)90288-6. Fundam Appl Toxicol. 1988. PMID: 3259520

4

Synergistic effect of detergents and aluminium phosphate on the humoral immune response to bacterial and viral membrane proteins.

Teerlink T, Beuvery EC, Evenberg D, van Wezel TL. Teerlink T, et al. Among authors: beuvery ec. Vaccine. 1987 Dec;5(4):307-14. doi: 10.1016/0264-410x(87)90157-5. Vaccine. 1987. PMID: 3124365

5

Single shot with tetanus toxoid in biodegradable microspheres protects mice despite acid-induced denaturation of the antigen.

Kersten GF, Donders D, Akkermans A, Beuvery EC. Kersten GF, et al. Among authors: beuvery ec. Vaccine. 1996 Dec;14(17-18):1627-32. doi: 10.1016/s0264-410x(96)00145-4. Vaccine. 1996. PMID: 9032891

6

Analytical, toxicological and immunological consequences of the use of N-ethyl-N'-(3-dimethylaminopropyl) carbodiimide as coupling reagent for the preparation of meningococcal group C polysaccharide-tetanus toxoid conjugate as vaccine for human use.

Beuvery EC, Speijers GJ, Lutz BI, Freudenthal D, Kanhai V, Haagmans B, Derks HJ. Beuvery EC, et al. Dev Biol Stand. 1986;63:117-28. Dev Biol Stand. 1986. PMID: 3091432

7

PAT for vaccines: the first stage of PAT implementation for development of a well-defined whole-cell vaccine against whooping cough disease.

Streefland M, van de Waterbeemd B, Happé H, van der Pol LA, Beuvery EC, Tramper J, Martens DE. Streefland M, et al. Among authors: beuvery ec. Vaccine. 2007 Apr 20;25(16):2994-3000. doi: 10.1016/j.vaccine.2007.01.015. Epub 2007 Jan 22. Vaccine. 2007. PMID: 17313999

8

Scale-up for bulk production of vaccine against meningococcal disease.

Baart GJ, de Jong G, Philippi M, van't Riet K, van der Pol LA, Beuvery EC, Tramper J, Martens DE. Baart GJ, et al. Among authors: beuvery ec. Vaccine. 2007 Aug 21;25(34):6399-408. doi: 10.1016/j.vaccine.2007.06.008. Epub 2007 Jun 26. Vaccine. 2007. PMID: 17658670

9

Immunogenicity of a pilot inactivated poliovirus vaccine with trypsin-treated type 3-component.

Piirainen L, Roivainen M, Litmanen L, Eskola J, Beuvery EC, Hovi T. Piirainen L, et al. Among authors: beuvery ec. Vaccine. 1997 Feb;15(2):237-43. doi: 10.1016/s0264-410x(96)00119-3. Vaccine. 1997. PMID: 9066044 Clinical Trial.

10

Randomised, controlled trial with the trypsin-modified inactivated poliovirus vaccine: assessment of intestinal immunity with live challenge virus.

Piirainen L, Stenvik M, Roivainen M, Eskola J, Beuvery EC, Hovi T. Piirainen L, et al. Among authors: beuvery ec. Vaccine. 1999 Mar 5;17(9-10):1084-90. doi: 10.1016/s0264-410x(98)00325-9. Vaccine. 1999. PMID: 10195618 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

81 results

Search Page